Posizioni attive di James Roger McIlroy
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Direttore/Membro del Consiglio | 01/03/2017 | - |
| Amministratore Delegato | 01/03/2017 | - | |
| Fondatore | 01/03/2017 | - | |
| Corporate Officer/Principal | 10/09/2018 | - |
Storia della carriera di James Roger McIlroy
Statistiche
Distribuzione geografica
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- James Roger McIlroy
- Esperienza
